Patent · US Expired

Insulin-like growth factor binding protein and pharmaceutical compositions

US5328891A · kind A · utility

12Cited by

10References

8Claims

0Family size

Assignees

Genentech, Inc. · US
Central Sydney Area Health Service · AU

Inventors

Robert C. Baxter · Sydney, AU
William I. Wood · Hillsborough, US

Key dates

Filing date	Jan 13, 1993
Grant date	Jul 12, 1994
Priority date	—
Expiry date	Jan 13, 2013

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

DNA isolates coding for insulin-like growth factor binding protein may be used to produce the protein via recombinant expression systems. Insulin-like growth factor binding protein, which generally has a molecular weight of about 53 kD on non-reducing SDS-PAGE, is useful as a binder to insulin-like growth factor and as a metabolic regulator.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.